The Clorox Company $CLX Shares Purchased by Pinnacle Associates Ltd.

Pinnacle Associates Ltd. increased its holdings in shares of The Clorox Company (NYSE:CLX) by 134.8% in the fourth quarter, Holdings Channel reports. The firm owned 24,623 shares of the company’s stock after acquiring an additional 14,134 shares during the period. Pinnacle Associates Ltd.’s holdings in Clorox were worth $2,483,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Center for Financial Planning Inc. acquired a new stake in Clorox during the 3rd quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC acquired a new stake in Clorox during the 3rd quarter worth approximately $25,000. Root Financial Partners LLC acquired a new stake in Clorox during the 3rd quarter worth approximately $29,000. Darwin Wealth Management LLC acquired a new stake in Clorox during the 2nd quarter worth approximately $29,000. Finally, Vision Financial Markets LLC increased its position in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Stock Performance

Shares of CLX opened at $90.47 on Friday. The business’s fifty day moving average price is $101.99 and its 200 day moving average price is $106.96. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $136.69. The stock has a market capitalization of $10.94 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the business posted $1.45 earnings per share. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts forecast that The Clorox Company will post 5.63 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were paid a dividend of $1.24 per share. The ex-dividend date was Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.5%. Clorox’s dividend payout ratio (DPR) is 80.52%.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 target price on shares of Clorox in a research report on Friday, May 1st. Jefferies Financial Group lowered their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $103.73.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.